Chemren Bio-Engineering Co., Ltd.

中文版

ENGLISH

News

New inhibitors-GSK2646264A

Inhibitor:LX4211

chemrenblock BioScience

WELCOME TO OUR STAND: E5A51 CP

Tel: 0519-85788828
Fax: 0519-89960117
Mobile: 13775037613
E-mail: sales@chemrenpharm.com
Add: 169 Qingliang Road, Changzhou, Jiangsu,China
QQ: 2500035664

Products > Others > > PD 123319 ditrifluoroacetate

Product name : PD 123319 ditrifluoroacetate

Item : CR1795

CAS : 136676-91-0

Enlarge Image

Back

←[Previous Product] [Next Product]→

Details:

Chemical Information

M.Wt	736.66	Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Formula	C35H34F6N4O7
CAS No	136676-91-0
Solvent & Solubility	H2O:40 mg/mL

References on PD 123319 ditrifluoroacetate

[1]. Blankley CJ, et al. Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. J Med Chem. 1991 Nov;34(11):3248-60.

[2]. Zhou J, et al. A novel angiotensin receptor subtype in rat mesangium. Coupling to adenylyl cyclase. Hypertension. 1993 Jun;21(6 Pt 2):1035-8.

[3]. Estrup TM, et al. No effect of angiotensin II AT(2)-receptor antagonist PD 123319 on cerebral blood flow autoregulation. J Renin Angiotensin Aldosterone Syst. 2001 Sep;2(3):188-92.

[4]. Brillante DG, et al. Effects of intravenous PD 123319 on haemodynamic and arterial stiffness indices in healthy volunteers. J Renin Angiotensin Aldosterone Syst. 2005 Sep;6(2):102-6.

[5]. Coleman CM, et al. Angiotensin AT1-receptor inhibition exacerbates renal injury resulting from partial unilateral ureteral obstruction in the neonatal rat. Am J Physiol Renal Physiol. 2007 Jul;293(1):F262-8.

Availability and price:
Stock : in stock
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to :sales@chemrenpharm.com

Related Products :

Uprosertib(GSK-2141795)

XEN445

Prucalopride